Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Effects of cannabinoids on the development of chick embryos in ovo
Umeå universitet, Medicinska fakulteten, Institutionen för farmakologi och klinisk neurovetenskap, Farmakologi. (Jacobsson)
Umeå universitet, Medicinska fakulteten, Institutionen för farmakologi och klinisk neurovetenskap, Farmakologi.
2019 (Engelska)Ingår i: Scientific Reports, E-ISSN 2045-2322, Vol. 9, artikel-id 13486Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

We have examined the effects of the synthetic cannabinoids HU 210 and HU 211, the plant-derived cannabidiol and the endogenous cannabinoid anandamide on the viability and development of chick embryos. Fertilized White Leghorn chicken eggs were injected with the test compounds or carrier vehicle, via a drilled small hole in the egg, directly into the egg yolk. After nine days of exposure, the embryonal viability, length and wet weight of embryos, and wet weight of brains were measured, and the development stages were assessed according to the Hamburger and Hamilton (HH) scale. The potent synthetic cannabinoid receptor agonist HU 210 and the non-psychotropic cannabidiol were embryotoxic at the highest concentrations examined (10µM and 50µM, respectively), with no viable embryos after the HU 210 injection, and 20% viability after the cannabidiol injections. The efects of HU 210 on the chick embryo were attenuated by α-tocopherol and the cannabinoid receptor antagonist AM251, whereas only α-tocopherol gave a statistically signifcant protection against the embryotoxic efects of cannabidiol. This study shows that exposure to plant-derived or synthetic cannabinoids during early embryonal development decreases embryonal viability. Extrapolation of data across species is of course difcult, but the data would argue against the use of cannabinoids, be it recreationally or therapeutically, during pregnancy

Ort, förlag, år, upplaga, sidor
Nature Publishing Group, 2019. Vol. 9, artikel-id 13486
Nyckelord [en]
cannabinoids, chick embryo, viability, Hamburger-Hamilton scale, α-tocopherol
Nationell ämneskategori
Farmakologi och toxikologi
Forskningsämne
toxikologi
Identifikatorer
URN: urn:nbn:se:umu:diva-51558DOI: 10.1038/s41598-019-50004-7ISI: 000486140100032PubMedID: 31530885Scopus ID: 2-s2.0-85072268656OAI: oai:DiVA.org:umu-51558DiVA, id: diva2:484047
Anmärkning

Originally included in thesis in manuscript form.

Tillgänglig från: 2012-01-31 Skapad: 2012-01-26 Senast uppdaterad: 2023-03-23Bibliografiskt granskad
Ingår i avhandling
1. Cannabinoids as modulators of cancer cell viability, neuronal differentiation, and embryonal development
Öppna denna publikation i ny flik eller fönster >>Cannabinoids as modulators of cancer cell viability, neuronal differentiation, and embryonal development
2012 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Alternativ titel[sv]
Effekter av cannabinoider på cancerceller, neuronal differentiering och embryonal utveckling
Abstract [en]

Cannabinoids (CBs) are compounds that activate the CB1 and CB2 receptors. CB receptors mediate many different physiological functions, and cannabinoids have been reported to decrease tumor cell viability, proliferation, migration, as well as to modulate metastasis.

In this thesis, the effects of cannabinoids on human colorectal carcinoma Caco-2 cells (Paper I) and mouse P19 embryonal carcinoma (EC) cells (Paper III) were studied.  In both cell lines, the compounds examined produced a concentration- and time-dependent decrease in cell viability. In Caco-2-cells, HU 210 and the pyrimidine antagonist 5-fluorouracil produced synergistic effects upon cell viability. The mechanisms behind the cytocidal effects of cannabinoids appear to be mediated by other than solely the CB receptor, and a common mechanism in Caco-2 and P19 EC cells was oxidative stress. However, in P19 EC cells the CB receptors contribute to the cytocidal effects possibly via ceramide production.

In paper II, the association between CB1 receptor immunoreactivity (CB1IR) and different histopathological variables and disease-specific survival of colorectal cancer (CRC) was investigated. In microsatellite stable (MSS) cases there was a significant positive association of the tumor grade with the CB1IR intensity. A high CB1IR is indicative of a poorer prognosis in MSS with stage II CRC patients.

Paper IV focused on the cytotoxic effects of cannabinoids during neuronal differentiation. HU 210 affected the cell viability, neurite formation and produced a decreased intracellular AChE activity. The effects of cannabinoids on embryonic development and survival were examined in Paper V, by repeated injection of cannabinoids in fertilized chicken eggs. After 10 days of incubation, HU 210 and cannabidiol (without CB receptor affinity), decreased the viability of chick embryos, in a manner that could be blocked by α-tocopherol (antioxidant) and attenuated by AM251 (CB1 receptor antagonist).

In conclusion, based on these studies, the cannabinoid system may provide a new target for the development of drugs to treat cancer such as CRC. However, the CBs also produce seemingly unspecific cytotoxic effects, and may have negative effects on the neuronal differentiation process. This may be responsible for, at least some of, the embryotoxic effects found in ovo, but also for the cognitive and neurotoxic effects of cannabinoids in the developing and adult nervous system.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå universitet, 2012. s. 48
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 1474
Nyckelord
Cannabinoids, cell viability, neuronal differentiation, colorectal cancer, chick embryo
Nationell ämneskategori
Farmakologi och toxikologi
Forskningsämne
biokemisk farmakologi; toxikologi
Identifikatorer
urn:nbn:se:umu:diva-51560 (URN)978-91-7459-358-7 (ISBN)
Disputation
2012-02-24, Sal E04, by 6E, Norrlands Universitetssjukhus, Umeå, 09:00 (Svenska)
Opponent
Handledare
Tillgänglig från: 2012-02-03 Skapad: 2012-01-26 Senast uppdaterad: 2018-06-08Bibliografiskt granskad

Open Access i DiVA

fulltext(2715 kB)357 nedladdningar
Filinformation
Filnamn FULLTEXT03.pdfFilstorlek 2715 kBChecksumma SHA-512
7634d466b7ff7d0cd2849721c83cb874ca4fb0eca25118815a167b41c7e06a97c98f8ba81d492150e81ca7d2c2e09f86ad60a29a4f79ecbdccdc812dde14e555
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Gustafsson, SofiaJacobsson, Stig OP

Sök vidare i DiVA

Av författaren/redaktören
Gustafsson, SofiaJacobsson, Stig OP
Av organisationen
Farmakologi
I samma tidskrift
Scientific Reports
Farmakologi och toxikologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 357 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 944 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf